Primary surgery for stage IB-IIA cervical cancer, including short-term and long-term morbidity and treatment in pregnancy.

J. F. Magrina

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Radical hysterectomy and pelvic lymphadenectomy are indicated for the treatment of cervical carcinoma that is localized clinically to the cervix and upper vagina. Intraoperative complications have been reported in 1.1%-7.4% of patients. Long-term complications include bladder dysfunction (2% at 3 years), urinary fistula (vesical, 0.8%; ureteral, 1.2%), stress urinary incontinence (29%), ureteral stricture (1%), rectal dysfunction (80%), severe constipation (5.3%), lymphocysts (20% by ultrasonography; 2% clinically), and lymphedema (10%). The operative mortality is 0.7%. The 5-year survival rate for patients with stage IB disease is 85.7% and for stage IIA is 69.6%. The recurrence rate is 27.2%. Recurrences are distributed equally between the pelvis and extrapelvic sites. Radical hysterectomy is the treatment of choice for pregnant patients with early cervical cancer. It affords termination or delivery of the pregnancy at the same time that the treatment is provided. For patients with stage I disease treated with radical hysterectomy, the survival rate is 92.1%.

Original languageEnglish (US)
Pages (from-to)53-59
Number of pages7
JournalJournal of the National Cancer Institute. Monographs
Issue number21
StatePublished - 1996

Fingerprint

Uterine Cervical Neoplasms
Hysterectomy
Morbidity
Pregnancy
Urinary Bladder
Survival Rate
Urinary Fistula
Recurrence
Stress Urinary Incontinence
Lymphedema
Intraoperative Complications
Vagina
Constipation
Therapeutics
Lymph Node Excision
Pelvis
Cervix Uteri
Ultrasonography
Pathologic Constriction
Carcinoma

Cite this

@article{d23f779f0b0b4d988d6e706e6ec42b27,
title = "Primary surgery for stage IB-IIA cervical cancer, including short-term and long-term morbidity and treatment in pregnancy.",
abstract = "Radical hysterectomy and pelvic lymphadenectomy are indicated for the treatment of cervical carcinoma that is localized clinically to the cervix and upper vagina. Intraoperative complications have been reported in 1.1{\%}-7.4{\%} of patients. Long-term complications include bladder dysfunction (2{\%} at 3 years), urinary fistula (vesical, 0.8{\%}; ureteral, 1.2{\%}), stress urinary incontinence (29{\%}), ureteral stricture (1{\%}), rectal dysfunction (80{\%}), severe constipation (5.3{\%}), lymphocysts (20{\%} by ultrasonography; 2{\%} clinically), and lymphedema (10{\%}). The operative mortality is 0.7{\%}. The 5-year survival rate for patients with stage IB disease is 85.7{\%} and for stage IIA is 69.6{\%}. The recurrence rate is 27.2{\%}. Recurrences are distributed equally between the pelvis and extrapelvic sites. Radical hysterectomy is the treatment of choice for pregnant patients with early cervical cancer. It affords termination or delivery of the pregnancy at the same time that the treatment is provided. For patients with stage I disease treated with radical hysterectomy, the survival rate is 92.1{\%}.",
author = "Magrina, {J. F.}",
year = "1996",
language = "English (US)",
pages = "53--59",
journal = "NCI Monographs",
issn = "1052-6773",
publisher = "Oxford University Press",
number = "21",

}

TY - JOUR

T1 - Primary surgery for stage IB-IIA cervical cancer, including short-term and long-term morbidity and treatment in pregnancy.

AU - Magrina, J. F.

PY - 1996

Y1 - 1996

N2 - Radical hysterectomy and pelvic lymphadenectomy are indicated for the treatment of cervical carcinoma that is localized clinically to the cervix and upper vagina. Intraoperative complications have been reported in 1.1%-7.4% of patients. Long-term complications include bladder dysfunction (2% at 3 years), urinary fistula (vesical, 0.8%; ureteral, 1.2%), stress urinary incontinence (29%), ureteral stricture (1%), rectal dysfunction (80%), severe constipation (5.3%), lymphocysts (20% by ultrasonography; 2% clinically), and lymphedema (10%). The operative mortality is 0.7%. The 5-year survival rate for patients with stage IB disease is 85.7% and for stage IIA is 69.6%. The recurrence rate is 27.2%. Recurrences are distributed equally between the pelvis and extrapelvic sites. Radical hysterectomy is the treatment of choice for pregnant patients with early cervical cancer. It affords termination or delivery of the pregnancy at the same time that the treatment is provided. For patients with stage I disease treated with radical hysterectomy, the survival rate is 92.1%.

AB - Radical hysterectomy and pelvic lymphadenectomy are indicated for the treatment of cervical carcinoma that is localized clinically to the cervix and upper vagina. Intraoperative complications have been reported in 1.1%-7.4% of patients. Long-term complications include bladder dysfunction (2% at 3 years), urinary fistula (vesical, 0.8%; ureteral, 1.2%), stress urinary incontinence (29%), ureteral stricture (1%), rectal dysfunction (80%), severe constipation (5.3%), lymphocysts (20% by ultrasonography; 2% clinically), and lymphedema (10%). The operative mortality is 0.7%. The 5-year survival rate for patients with stage IB disease is 85.7% and for stage IIA is 69.6%. The recurrence rate is 27.2%. Recurrences are distributed equally between the pelvis and extrapelvic sites. Radical hysterectomy is the treatment of choice for pregnant patients with early cervical cancer. It affords termination or delivery of the pregnancy at the same time that the treatment is provided. For patients with stage I disease treated with radical hysterectomy, the survival rate is 92.1%.

UR - http://www.scopus.com/inward/record.url?scp=0030338349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030338349&partnerID=8YFLogxK

M3 - Article

C2 - 9023829

AN - SCOPUS:0030338349

SP - 53

EP - 59

JO - NCI Monographs

JF - NCI Monographs

SN - 1052-6773

IS - 21

ER -